These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4221212)

  • 21. [EXPERIMENTAL STUDIES ON THE SKELETAL MUSCLE FOLLOWING TOURNIQUET.EFFECT OF TOURNIQUET ON COAGULATION AND FIBRINOLYSIS IN DOGS].
    SAKAHASHI H
    Sapporo Igaku Zasshi; 1963 Jul; 24():29-39. PubMed ID: 14130272
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombus dissolution.
    Sharp AA
    J Clin Pathol; 1969 May; 22(3):369-71. PubMed ID: 4239465
    [No Abstract]   [Full Text] [Related]  

  • 23. The thrombolytic effect of miniplasmin in a canine model of femoral artery thrombosis.
    Fu J; Ren J; Zou L; Bian G; Li R; Lu Q
    Thromb Res; 2008; 122(5):683-90. PubMed ID: 18328540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COMPARISON OF A FIBRINOLYSIN AND HEPARIN ON INDUCED VENOUS THROMBOSIS AND THROMBOLYSIS.
    WILLIAMS RD; KARAFFA F
    Surg Gynecol Obstet; 1965 Aug; 121():309-12. PubMed ID: 14320378
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinolysis and outflow resistance in the eye.
    Pandolfi M
    Am J Ophthalmol; 1967 Dec; 64(6):1141-8. PubMed ID: 4229211
    [No Abstract]   [Full Text] [Related]  

  • 26. [New data on the importance of damage to the vascular wall in the mechanism of intravascular thrombus formation].
    Babuda VP; Rukazenkova ZhN; Khnychev SS
    Patol Fiziol Eksp Ter; 1966; 10(4):14-7. PubMed ID: 4230262
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on fibrinolysis. I. A circulating substance capable of converting plasmin-sensitive to plasmin-resistant clots.
    RABINER SF; ROBBINS KC
    Proc Soc Exp Biol Med; 1962 Dec; 111():701-6. PubMed ID: 13972853
    [No Abstract]   [Full Text] [Related]  

  • 28. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinolysin treatment of induced venous thrombosis in the dog.
    WILSON JS
    Surgery; 1960 Sep; 48():469-80. PubMed ID: 13845091
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of human plasma on thrombelastographic patterns produced by fibrinolytic agents in fibrin clots.
    Egeblad K; Astrup T
    Br J Haematol; 1967 Jan; 13(1):10-3. PubMed ID: 4225132
    [No Abstract]   [Full Text] [Related]  

  • 32. Fibrinolysis. VII. Clot lysis, coagulation, and fibrinolytic mechanisms after administration of aspergillin O (mold fibrinolysin) in man.
    KARACA M; STEFANINI M; MELE R
    J Lab Clin Med; 1962 May; 59():799-814. PubMed ID: 14453834
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombolytic therapy in an isolated limb.
    Goodman GR; Tersigni S; Li K; Lawrence PF
    Ann Vasc Surg; 1993 Nov; 7(6):512-20. PubMed ID: 8123453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Henkin J
    Thromb Haemost; 1997 May; 77(5):1025-30. PubMed ID: 9184422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ARTIFICIAL PRODUCTION OF INTRA-ARTERIAL THROMBOSIS.
    GELMANN HO; SILVER SR; SABETY AM
    J Med Soc N J; 1963 Jun; 60():241-3. PubMed ID: 14082082
    [No Abstract]   [Full Text] [Related]  

  • 36. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW.
    LIEBERMAN J
    Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of autonomic nervous system in reflectory defense reaction of the frog's organism upon introduction of plasmin into the blood stream].
    Kalishevskaia TM; Morozova GA; Andreenko GV
    Dokl Akad Nauk SSSR; 1966 Mar; 167(1):235-7. PubMed ID: 4231384
    [No Abstract]   [Full Text] [Related]  

  • 38. [Increasing the local concentration of fibrinolysin and thrombolysis rate using magnetic fluid in a model of occlusive thrombosis].
    Rusetskiĭ AN; Ruuge EK; Meertsyk FE
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(1):89-93. PubMed ID: 2939853
    [No Abstract]   [Full Text] [Related]  

  • 39. The lysis of intravascular thrombi in rabbits with human plasmin (fibrinolysin).
    GROSSI CE; CLIFFTON EE; CANNAMELA DA
    Blood; 1954 Apr; 9(4):310-20. PubMed ID: 13149617
    [No Abstract]   [Full Text] [Related]  

  • 40. Fibrinolysin therapy of thrombophlebitis and pulmonary embolism--a double-blind study.
    SANDY JT; PERRET TS
    Can Med Assoc J; 1963 Jun; 88(23):1139-46. PubMed ID: 13976284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.